Compare · BYRN vs DHR
BYRN vs DHR
Side-by-side comparison of Byrna Technologies Inc. (BYRN) and Danaher Corporation (DHR): market cap, price performance, sector, and recent activity on the wire.
Summary
- BYRN operates in Miscellaneous, while DHR operates in Industrials - the two are in different parts of the market.
- DHR is the larger of the two at $129.97B, about 913.7x BYRN ($142.2M).
- Over the past year, BYRN is down 78.9% and DHR is down 10.3% - DHR leads by 68.6 points.
- DHR has been more active in the news (19 items in the past 4 weeks vs 1 for BYRN).
- DHR has more recent analyst coverage (25 ratings vs 10 for BYRN).
- Company
- Byrna Technologies Inc.
- Danaher Corporation
- Price
- $6.27-0.16%
- $183.66-2.60%
- Market cap
- $142.2M
- $129.97B
- 1M return
- +21.98%
- +10.34%
- 1Y return
- -78.86%
- -10.30%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 1
- 19
- Recent ratings
- 10
- 25
Byrna Technologies Inc.
Byrna Technologies Inc., a less-lethal defense technology company, develops and manufactures less-lethal munitions. The company offers a Byrna line of handheld personal security devices, including the Byrna HD, a .68 caliber handheld personal security device that is designed to be used by civilians and private security professionals, as well as Byrna HD magazines, launchers, and projectiles. It operates in the United States, Canada, and South Africa. The company was formerly known as Security Devices International, Inc. and changed its name to Byrna Technologies Inc. in March 2020. Byrna Technologies Inc. was incorporated in 2005 and is headquartered in Andover, Massachusetts.
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Latest BYRN
- Byrna Technologies Launches Media Partnership with Fox Sports Through iHeartMedia to Expand National Reach
- Byrna Technologies Sets Upcoming Investor Conference Schedule
- Chief Financial Officer Kearnes Laurilee converted options into 2,313 shares, increasing direct ownership by 33% to 9,387 units (SEC Form 4)
- Amendment: SEC Form 4 filed by Ganz Bryan
- SEC Form SCHEDULE 13G filed by Byrna Technologies Inc.
- SEC Form 4 filed by Ganz Bryan
- Byrna Technologies Promotes Matthew Campagni to Chief Strategy Officer
- Byrna Technologies downgraded by Craig Hallum with a new price target
- Byrna Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by Byrna Technologies Inc.
Latest DHR
- Danaher Completes Acquisition of Masimo Corporation
- SEC Form S-8 filed by Danaher Corporation
- Sirius XM Holdings Set to Join S&P MidCap 400
- Danaher Corporation filed SEC Form 8-K: Other Events
- DZ Bank initiated coverage on Danaher with a new price target
- Wolfe Research resumed coverage on Danaher
- SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools
- SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations
- Citigroup resumed coverage on Danaher with a new price target
- Henry Schein Announces the Election of William K. "Dan" Daniel as Independent Chairman of the Board